The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Mesenchymal stem/stromal cells in cancer therapy
Open accessAbstract
The multipotent mesenchymal stem/stromal cells (MSCs), initially discovered from bone marrow in 1976, have been identified in nearly all tissues of human body now. The multipotency of MSCs allows them to give rise to osteocytes, chondrocytes, adipocytes, and other lineages. Moreover, armed with the immunomodulation capacity and tumor-homing property, MSCs are of special relevance for cell-based therapies in the treatment of cancer. However, hampered by lack of knowledge about the controversial roles that MSC plays in the crosstalk with tumors, limited progress has been made with regard to translational medicine. Therefore, in this review, we discuss the prospects of MSC-associated anticancer strategies in light of therapeutic mechanisms and signal transduction pathways. In addition, the clinical trials designed to appraise the efficacy and safety of MSC-based anticancer therapies will be assessed according to published data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The adaptability of MSCs, although beneficial in regenerative medicine, may elevate the risk of these cells unintentionally developing tumorigenic characteristics in the context of malignancy [300, 301].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent meta-analysis of MSC therapies in oncology revealed that modified MSCs may develop tumorigenic properties under prolonged culture conditions, especially with extensive passaging or exposure to pro-inflammatory cytokines.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies indicate that genetic modifications intended to enhance the regenerative potential of mesenchymal stem cells (MSCs), such as the overexpression of fibroblast growth factor-2 (FGF-2) or hepatocyte growth factor (HGF), may unintentionally promote tumor growth.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent investigations have demonstrated that MSCs possess significant plasticity, enabling them to adapt dynamically to their microenvironment.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Studies indicate that MSCs derived from MM patients possess genetic mutations that increase their susceptibility to malignant transformation.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P. H., Ugarte, D. A. D., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,762
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Stöckl, S., Göttl, C., Grifka, J. K., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,670
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“The tumor homing property of MSCs Since the development of cancer shares multiple similarities with wound healing, tumors are also known as “wounds that do not heal” [109].”
BackgroundMatrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,277
Research works printed but not linked: 2
- Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma. J Exp Med. 2006;203(5):1235–47. · DOI · Paper page
- Wang W, Zhong W, Yuan J, Yan C, Hu S, Tong Y, et al. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma. Oncotarget. 2015;6(39):42276–89. · DOI
Cited by
Sorted by citations
Items 101–200 of 374
Fang, C., Zeng, Z., Ye, J., Ni, B., Zou, J., & Zhang, G. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04220-w · Cited by 14
Ferroptosis Inducers Kill Mesenchymal Stem Cells Affected by Neuroblastoma
Li, X., Wang, Q., Xu, C., Zhang, L., Zhou, J., Lv, J., Xu, M., & Jiang, D. (2023) · Cancers · doi:10.3390/cancers15041301 · Cited by 14
Luo, L., Zhang, S., Gong, J., Zhang, J., Xie, P., Yin, J., Zhang, M., Zhang, C., Chen, H., Liu, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202410151 · Cited by 13
From inflammation to metastasis: The central role of miR-155 in modulating NF-κB in cancer
Mohan, S., Hakami, M. A., Dailah, H. G., Khalid, A., Najmi, A., Zoghebi, K. A., Halawi, M. A., & Alotaibi, T. M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154962 · Cited by 13
Engineering Microorganisms for Cancer Immunotherapy
Liu, D., Yu, L., Rong, H., Liu, L., & Yin, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304649 · Cited by 13
Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy
Li, K., Nie, H., Jin, R., & Wu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1397005 · Cited by 17
The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View
Mosna, F. (2024) · Cancers · doi:10.3390/cancers16132359 · Cited by 13
The effects of mesenchymal stem cells on the chemotherapy of colorectal cancer
Wang, M., Li, J., Wang, D., Xin, Y., & Liu, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114373 · Cited by 13
Cai, Q., Cai, W., Liu, Y., Li, M., Xiang, S.-E., Ji, H., Zhang, Z., Yu, N., Hu, Y., Hu, Y., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104854 · Cited by 13
Peng, L., Liang, Y., Guo, X., Zhang, Q. W., Gao, Z., Kong, X., Zhang, H., Zhu, B., & Cui, D. (2025) · Nanoscale Advances · doi:10.1039/d5na00513b · Cited by 14
Wang, Q., Tang, X., Wang, Y., Zhang, D.-Y., Li, X., & Liu, S. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.009 · Cited by 12
Arjmand, B., Alavi-Moghadam, S., Sarvari, M., Rezaei–Tavirani, M., Mafi, A. R., Arjmand, R., Nikandish, M., Nasli‐Esfahani, E., & Larijani, B. A. (2023) · Inflammopharmacology · doi:10.1007/s10787-022-01132-6 · Cited by 13
Wang, T., Gong, Y., Lin, H., Li, X., Liang, J., Yuan, X., Li, C., Hu, Z., Chen, H., Xiao, J., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70084 · Cited by 11
Li, L., Zhang, X., & Chen, Y. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673273833231220062213 · Cited by 11
Wu, L., Zhang, L., Huang, M., Wu, Y. L., Jin, S., Zhang, Y., Gan, X., Yu, T., Yu, G., Zhang, J., et al. (2024) · Biomolecules · doi:10.3390/biom14111353 · Cited by 12
Feng, Z., Yang, Y., Liu, X., Sun, H., Wen, B.-Y., Chen, Z., & Wei, B. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114017 · Cited by 11
Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases
Li, L., He, Y., Zhao, J., Yin, H., Feng, X., Fan, X., Wu, W., & Lu, Q. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09030-9 · Cited by 11
Stem Cell for Cancer Immunotherapy: Current Approaches and Challenges
Ali, Z. A., Ferdous, U. T., Nzila, A. M., Easmin, F., Shakoor, A., Zia, A. W., & Uddin, S. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10933-5 · Cited by 13
Fath, M. K., Banan, Z. M., Barati, R., Mohammadrezakhani, O., Ghaderi, A., Hatami, A., Ghiabi, S., Zeidi, N., Asgari, K., Payandeh, Z., et al. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.02.001 · Cited by 10
Wang, X., Li, W., Hao, M., Yang, Y., & Xu, Y. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101458 · Cited by 11
Zhang, Z., Shao, S., Liu, X., & Tong, Z. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28702 · Cited by 11
Zhang, Y., Wang, Y., Li, B., Han, Y., Du, J., Chen, Y., Ye, J., Luo, C., Chen, H., Peng, F., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114297 · Cited by 10
Roy, N. S., Kumari, M., Alam, K., Bhattacharya, A., Kaity, S., Kaur, K., Ravichandiran, V., & Roy, S. (2024) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ad9dcb · Cited by 11
Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance
Zhang, H., Wu, B., Wang, Y. N., Du, H., & Fang, L. (2025) · Molecules · doi:10.3390/molecules30030498 · Cited by 10
Sun, Y., Wu, J., Zan, J., Li, Z., Liu, L., & Ding, G. (2025) · Polymers · doi:10.3390/polym17111430 · Cited by 10
Singh, P., Metkari, S., Tripathi, A., & Bhartiya, D. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10632-z · Cited by 10
Zhang, J., Suo, M., Wang, J., Liu, X., Huang, H., Wang, K., Liu, X., Sun, T., Li, Z., & Liu, J. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1646 · Cited by 10
Hao, J., Yu, X., Tang, K., Ma, X., Lu, H., & Wu, C. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.06.016 · Cited by 10
Paganelli, A., Rossi, E. G., & Magnoni, C. (2022) · Stem Cells and Development · doi:10.1089/scd.2022.0189 · Cited by 11
Shah, S., & Lucke-Wold, B. P. (2024) · Cancers · doi:10.3390/cancers16162892 · Cited by 9
Navigating stem cell culture: insights, techniques, challenges, and prospects
Górska, A., Trubalski, M., Borowski, B., Brachet, A., Szymańczyk, S., & Markiewicz, R. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1435461 · Cited by 10
Zou, X., & Brigstock, D. R. (2024) · Biomedicines · doi:10.3390/biomedicines12122848 · Cited by 10
Jin, F., Wei, X., Liu, Y., Tang, L., Ren, J., Yang, J., Lin, C., Hu, J., Sun, M., Li, G., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123091 · Cited by 11
Self-citationStrategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines
Wu, J., Liang, J., Zhang, Y., Dong, C., Tan, D., Wang, H., Zheng, Y., & He, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146879 · Cited by 9
Kucharczyk, H., Tarnowski, M., & Tkacz, M. (2025) · Molecules · doi:10.3390/molecules30244808 · Cited by 9
Selenium-Containing Compounds in Breast Cancer Therapy
Varlamova, E. G. (2026) · Biological Trace Element Research · doi:10.1007/s12011-026-05026-4 · Cited by 9
Large-scale expansion of human umbilical cord-derived mesenchymal stem cells using PLGA@PLL scaffold
Liu, Y., Amissah, O. B., Huangfang, X., Wang, L., Habimana, J. D. D., Lv, L., Ding, X., Li, J., Chen, M., Zhu, J., et al. (2023) · Bioresources and Bioprocessing · doi:10.1186/s40643-023-00635-6 · Cited by 9
Weng, J., Fan, H., Liu, H., Tang, S., & Zheng, Y. (2023) · Stem Cells International · doi:10.1155/2023/9974098 · Cited by 9
Yao, C., Xin, H., Liu, S., She, P., Ma, Y., Hu, M., & Jin, Y. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.6.4 · Cited by 9
Exploring the Tumor-Associated Risk of Mesenchymal Stem Cell Therapy in Veterinary Medicine
Jeung, S.-Y., Kim, S., Ah, J.-G., Seo, S., Jan, U., Lee, H., & Lee, J. I. (2024) · Animals · doi:10.3390/ani14070994 · Cited by 8
Afkhami, H., Yarahmadi, A., Bostani, S., Yarian, N., Haddad, M. S., Lesani, S. S., Aghaei, S. S., & Zolfaghari, M. R. (2024) · Discover Oncology · doi:10.1007/s12672-024-01590-0 · Cited by 10
Single-cell technology for cell-based drug delivery and pharmaceutical research
Hu, H., Fan, Y., Wang, J., Zhang, J., Lyu, Y., Hou, X., Cui, J., Zhang, Y., Gao, J., Zhang, T., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113587 · Cited by 8
Advances in cell therapy for orthopedic diseases: bridging immune modulation and regeneration
Wang, J., Xu, S., Chen, B., & Qin, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1567640 · Cited by 10
Veilleux, C., Roy, M.-È., Zgheib, A., Desjarlais, M., & Annabi, B. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02298-6 · Cited by 8
Zhang, X., Zhang, Z., Zhang, Z., & Zhang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1628573 · Cited by 12
Santoro, A., Grimaldi, M., Marino, C., Napolitano, E., Buonocore, M., & D’Ursi, A. M. (2025) · Life · doi:10.3390/life16010010 · Cited by 8
Zavareh, V. A., Eslampoor, N., Panahi-Alanagh, S., Malekmohammad, L., & Stanek, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1762630 · Cited by 9
Developments and challenges in neoadjuvant therapy for locally advanced pancreatic cancer
Zhou, B., Zhang, S., Chen, G., & Chen, P. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i35.5094 · Cited by 8
Wu, J., Feng, Y., Feng, Y., He, X., Chen, Z., Lan, D., Wu, X., Wen, J., Tsung, A., Wang, X., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112410 · Cited by 8
Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells
Garza-Treviño, E. N., Quiroz-Reyes, A. G., González, P. D., Murillo, J. A. R., Islas, J. F., Saavedra-Alonso, S., & González-Villarreal, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147791 · Cited by 8
Huang, M., Liu, Y., Zhang, L., Wang, S., Wang, X., & He, Z. (2024) · Biomolecules · doi:10.3390/biom14111354 · Cited by 8
Liu, H., Ji, M. H., Yang, T., Zou, S., Qiu, X., Zhan, F., Chen, J., Yan, F., Ding, F., & Li, P. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00573.2024 · Cited by 8
Saadh, M. J., Mustafa, M. A., Malathi, H., Ahluwalia, G., Kaur, S., Faisal, A. N., Alubiady, M. H. S., Al‐Abdeen, S. H. Z., Shakier, H. G., Ali, Z. H., et al. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105938 · Cited by 7
Perovskites as Multiphoton Fluorescence Contrast Agents for In Vivo Imaging
Nath, P., Liversage, A. R., Mortensen, L. J., & Ray, A. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c08672 · Cited by 7
Li, D., Yang, Y., Zheng, G., Meng, L., Shang, L., Ren, J., Wang, L., & Bao, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1495978 · Cited by 8
Chen, F., Cen, H., Mao, D., & Feng, R. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13022 · Cited by 7
Zheng, J., Jiang, X., Li, Y., & Gao, J. (2023) · MedComm · doi:10.1002/mco2.313 · Cited by 8
Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents
Waqar, M. A., Zaman, M., Khan, R., Rahman, M. S. U., & Majeed, I. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2347356 · Cited by 7
Liu, X., Kim, J. H., Li, X., & Liu, R. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124732 · Cited by 10
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
Zhao, J., Lin, B.-L., Luo, C. H., Yi, Y.-L., Huang, P., Chen, Y., Zhao, S., Huang, Z.-J., Ma, X., & Huang, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05794-4 · Cited by 7
Shao, Y., Du, Y., Chen, Z., Xiang, L., Tu, S., Feng, Y., Hou, Y., Kou, X., & Ai, H. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04132-9 · Cited by 7
Adipose-derived mesenchymal stromal/stem cells in type 1 diabetes treatment
Sood, V., Ricioli, H., Njoku, G. C., Primavera, R., Dietrich, S., Thakor, A. S., Pociot, F., & Yarani, R. (2025) · Communications Biology · doi:10.1038/s42003-025-08244-z · Cited by 7
Update on Mesenchymal Stem Cells: A Crucial Player in Cancer Immunotherapy
Taeb, S., Rostamzadeh, D., Mafi, S., Mofatteh, M., Zarrabi, A., Hushmandi, K., Safari, A., Khodamoradi, E., & Najafi, M. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666221226143814 · Cited by 7
Mesenchymal stem cells: Guardians of women's health
Gao, G., Li, L., Li, C., Liu, D., Wang, Y., & Li, C. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.10.011 · Cited by 6
NKG2D-CAR-targeted iPSC-derived MSCs efficiently target solid tumors expressing NKG2D ligand
Tang, S., Zhang, Y., Wang, P., Tang, Q., Liu, Y., Lu, F., Han, M., Zhou, M., Hu, Q. N., Feng, M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112343 · Cited by 6
Immunocompetent tumor-on-a-chip: A translational tool for drug screening and cancer therapy
Liang, A., Tao, T., Chen, J., Yang, Y., Zhou, X., Zhu, X. M., & Yu, G. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104716 · Cited by 6
Yang, F., Chen, L., Shi, Y., Wang, L., & Tong, M. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101288 · Cited by 6
Saadh, M. J., Alhuthali, H. M., Aníbal, O. G., Asenjo‐Alarcón, J. A., Younus, D. G., Alhili, A., Adhab, Z. H., Alsalmi, O. A., Gharib, A. F., Pecho, R. D. C., et al. (2023) · Cell Biology International · doi:10.1002/cbin.12098 · Cited by 6
Isolation and characterization of feline endometrial mesenchymal stem cells
Park, M. K., & Song, K. (2024) · Journal of Veterinary Science · doi:10.4142/jvs.23267 · Cited by 6
Qi, Y., Wang, X., Bai, Z., Xu, Y., Lu, T., Zhu, H., Zhang, S., Wu, Z., Liu, Z., He, Z., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30968 · Cited by 6
Zinger, G., Gronovich, Y., Lotan, A. M., & Gabbay, R. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137148 · Cited by 6
Feng, Z., Zuo, Y., Shen, J., Zhao, Q., Cao, Z. Q., Li, X., & Wang, Z. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102574 · Cited by 6
Dai, Q., Zhu, D., Du, X.-M., Tan, H., & Chen, Q. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02635-1 · Cited by 7
Kumari, M., Alam, K., Bhattacharya, A., Roy, N. S., Madhasu, V., Guchhait, B., Dan, S., Sett, S., Chakrabarti, J., Mandal, C., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1594405 · Cited by 6
Yang, X., Zheng, M., Ning, Y., Sun, J., Yu, Y., & Zhang, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04284-3 · Cited by 6
Yuan, H., Li, S., Zhao, Z., & Wang, Y. (2023) · Organogenesis · doi:10.1080/15476278.2023.2285836 · Cited by 6
Li, Z., Zheng, X., Xia, H., 陆龙, Chen, X., Chen, Y., Wu, J., Shi, Y., & Wu, C. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08440-7 · Cited by 5
Li, C.-M., Wang, Q.-Y., Chen, Z., Wang, C., Xie, Y., & Gao, L. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06922-4 · Cited by 5
Tu, L., Gao, T., Shen, P., & Wang, B. (2026) · Biological Research · doi:10.1186/s40659-026-00687-w · Cited by 5
Yoon, Y., Kim, C. W., Kim, M. Y., Baik, S. K., Jung, P. Y., & Eom, Y. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021325 · Cited by 5
Wan, Z., Wang, X., Fu, Z., Ma, Y., Dai, G., Gong, X., Chen, G., & Yang, L. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09499-1 · Cited by 5
Liu, Z., Liu, G., Lin, Z., Chen, Y., Chen, P., Hu, Y., Yu, B., & Jiang, N. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03781-6 · Cited by 5
Mesenchymal Stem Cell-Loaded Hydrogel Improves Surgical Treatment for Chronic Cerebral Ischemia
Kang, H., Huang, Y., Peng, H., Zhang, X., Liu, Y., Liu, Y., Xia, Y., Liu, S., Wu, Y.-Q., Wang, S., et al. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01274-5 · Cited by 5
Gonzalez‐Rubio, J., Zeevaert, K., Buhl, E. M., Schedel, M., Jockenhoevel, S., Cornelissen, C. G., Wagner, W., & Thiebes, A. L. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123298 · Cited by 6
Song, D. J., He, C., Ocansey, D. K. W., Wang, B., Wu, Y., & Mao, F. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103861 · Cited by 5
Zhu, Y., Bao, S., Yin, X., Yu, M., Wang, Q., & Dong, C. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112364 · Cited by 7
The rise of exosome-mediated mechanisms in MSC therapy
Liu, W., Chen, S., Wang, Y., & Gong, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06747-1 · Cited by 5
Emerging Therapeutics and Delivery
Dash, A. K., Medi, B. M., Sarrami, B., Hasanzad, M., Singh, S., & Shukla, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99796-6.00003-5 · Cited by 5
Utilization of Hydrogels in Mesenchymal Stem Cell-Based Therapy for Kidney Diseases
Peng, J., Yang, T., Chen, S., Deng, N., Luo, X., Liao, R., & Su, B. (2023) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0196 · Cited by 5
Zhou, Y., Li, Y., Wang, H., Sun, H., Su, J., Fan, Y., Xing, W., & Fu, J. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x287102240101060146 · Cited by 5
Huang, M., Zhou, P., Yang, H., Wu, D., Zhao, N., Yao, G., Tang, X., & Sun, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111485 · Cited by 5
Hasannejad, F., Bahraminasab, M., Farahmand, L., Darvishi, B., Nooshabadi, V. T., Parsaei, H., Salehi, M., Jalili, N., Javidi, M. A., Shayeghan, M., et al. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106144 · Cited by 5
Chiu, A., Rutkowski, J. M., Zhang, Q., & Zhao, F. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403551 · Cited by 5
Mesenchymal stem cell exosomes: a promising delivery system for glioma therapy
Ma, T., Su, G., Wu, Q., Shen, M., Feng, X., & Zhang, Z. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2023-0482 · Cited by 5
Oncolytic Therapy: Delivery System and New Therapeutic Strategies for Cancer
Jin, S., Zhang, Y., Zhou, Z., Zhang, Y., Yu, T., Xu, R., Xu, L., Zhang, J., Zhang, L., Yang, S., et al. (2026) · MedComm · doi:10.1002/mco2.70725 · Cited by 4
Du, P., Tao, X., Harati, J., Shi, Y. X., Xiao, L., Li, X., Pan, H., & Wang, P. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04085-5 · Cited by 4
Ji, C., & Cheng, W. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103157 · Cited by 4
Engineered nanomedicine targets liver cancer stem cells to treat liver cancer disease
Huang, F., Chen, L., Zhang, X., Tian, S., Han, Y., Hu, M., He, L., & Luo, R. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01278c · Cited by 4
Hao, J., Zakershahrak, M., Ly, P., Le, A. D., Yu, W., Gates, J. C., & Chen, C. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07786-y · Cited by 5
Wu, X., Ma, Z., Yang, Y., Mu, Y., & Wu, D. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03604-0 · Cited by 4
Metadata
- Authors
- Lan, T., Luo, M., & Wei, X.
- Affiliations
- Sichuan University (CN)
- Corresponding author
- Luo, Min
- Wei, Xiawei
- ORCID
- Venue
- Journal of Hematology & Oncology
- Published
- 2021-11-17
- Volume
- 14
- Issue
- 1
- Pages
- 195-195
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC8596342
- OpenAlex
- W3211554128
- Cited by
- 374
- References
- 205
- Citations by year
- 2026: 63 · 2025: 105 · 2024: 103 · 2023: 91 · 2022: 12
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation Regional Innovation and Development (U19A2003)
- National Major Scientific and Technological Special Project for “Significant New Drugs Development” (2018ZX09733001)
- Excellent Youth Foundation of the Sichuan Scientific Committee Grant in China (2019JDJQ008)
- Development Program of China (2016YFA0201402)
- National Natural Science Foundation of China (31800773)
- Sichuan Science and Technology Program (2019YJ0063)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- mesenchymal stem cells, cancer therapy, cell therapy, immunomodulation, tumor homing, signaling pathways, clinical trials, translational medicine
- MeSH terms
- Translational Science, Biomedical, Animals, Humans, Neoplasms, Mesenchymal Stem Cell Transplantation, Immunomodulation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
